1. Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice. Adachi K, Tsutsui H, Seki E, Nakano H, Takeda K, Okumura K, Van Kaer L, Nakanishi K (2004) Int Immunol 16(6): 787-98
    › Primary publication · 15096477 (PubMed)
  2. CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice. Yang JQ, Chun T, Liu H, Hong S, Bui H, Van Kaer L, Wang CR, Singh RR (2004) Eur J Immunol 34(6): 1723-32
    › Primary publication · 15162443 (PubMed) · PMC2291526 (PubMed Central)
  3. CD1d1-dependent control of the magnitude of an acute antiviral immune response. Roberts TJ, Lin Y, Spence PM, Van Kaer L, Brutkiewicz RR (2004) J Immunol 172(6): 3454-61
    › Primary publication · 15004145 (PubMed)
  4. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Wilson MT, Johansson C, Olivares-Villagómez D, Singh AK, Stanic AK, Wang CR, Joyce S, Wick MJ, Van Kaer L (2003) Proc Natl Acad Sci U S A 100(19): 10913-8
    › Primary publication · 12960397 (PubMed) · PMC196902 (PubMed Central)
  5. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. Chefalo PJ, Grandea AG, Van Kaer L, Harding CV (2003) J Immunol 170(12): 5825-33
    › Primary publication · 12794107 (PubMed)
  6. Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. Yang JQ, Saxena V, Xu H, Van Kaer L, Wang CR, Singh RR (2003) J Immunol 171(8): 4439-46
    › Primary publication · 14530371 (PubMed)
  7. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. Yoshimoto T, Min B, Sugimoto T, Hayashi N, Ishikawa Y, Sasaki Y, Hata H, Takeda K, Okumura K, Van Kaer L, Paul WE, Nakanishi K (2003) J Exp Med 197(8): 997-1005
    › Primary publication · 12695491 (PubMed) · PMC2193873 (PubMed Central)
  8. Natural killer T cells as targets for therapeutic intervention in autoimmune diseases. Wilson MT, Van Kaer L (2003) Curr Pharm Des 9(3): 201-20
    › Primary publication · 12570826 (PubMed)
  9. Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. Shao H, Van Kaer L, Sun SL, Kaplan HJ, Sun D (2003) J Autoimmun 21(1): 37-45
    › Primary publication · 12892734 (PubMed)
  10. Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. Yang JQ, Singh AK, Wilson MT, Satoh M, Stanic AK, Park JJ, Hong S, Gadola SD, Mizutani A, Kakumanu SR, Reeves WH, Cerundolo V, Joyce S, Van Kaer L, Singh RR (2003) J Immunol 171(4): 2142-53
    › Primary publication · 12902521 (PubMed)